[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364768-105":59,"doc-detail-364768-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-nup62s-role-in-cancer-progression-tumor-immunity-and-treatment-response-insights-from-multi-omics-analysis","Exploring NUP62’s role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis","","NUP62, a nuclear pore complex component, is linked to cellular functions and cancer progression, yet its expression patterns, prognostic relevance, connections to tumor immunity, and drug sensitivity across cancers remain insufficiently characterized. This study integrated multi-omics analyses with experimental validation in gastric cancer to assess NUP62 expression, mutational features, functional roles, and clinical associations, including immune microenvironment relationships, pathway involvement, and chemotherapy response correlations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-nup62s-role-in-cancer-progression-tumor-immunity-and-treatment-response-insights-from-multi-omics-analysis/364768/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-nup62s-role-in-cancer-progression-tumor-immunity-and-treatment-response-insights-from-multi-omics-analysis/364768.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about NUP62?","Question",{"text":112,"@type":113},"It examines how NUP62 expression relates to cancer progression, tumor immunity, prognosis, and treatment response, and whether these relationships differ across multiple cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were NUP62 expression and immune associations analyzed?",{"text":117,"@type":113},"The study used multi-omics data from TCGA, GTEx, and CPTAC, plus tools such as SangerBox, TIMER 2.0, and GSEA to evaluate links between NUP62 and the tumor immune microenvironment and signaling pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"How was NUP62 validated in gastric cancer?",{"text":121,"@type":113},"NUP62 mRNA and protein levels in gastric cancer tissues were measured using immunohistochemistry and RT-PCR, showing higher levels in tumor tissues than in adjacent normal tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364768,1790722423,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 03 March 2025  \nDOI 10.3389/fimmu.2025.1559396  \nOPEN ACCESS  \nEDITED BY  \nLei Huang,  \nUniversity of Massachusetts Medical School, United States  \nREVIEWED BY  \nYuejia Deng,  \nTexas A and M University, United States Yue Liu,  \nThe University of Texas at Austin, United States  \n*CORRESPONDENCE  \nDejun Cui  \n [cuidejun@gz5055.com](cuidejun@gz5055.com)[ ](cuidejun@gz5055.com)Chen Li  \n [chen.li.scholar@outlook.com](chen.li.scholar@outlook.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 12 January 2025  \nACCEPTED 17 February 2025  \nPUBLISHED 03 March 2025  \nCITATION  \nChen L, He Y, Duan M, Yang T, Chen Y, Wang B, Cui D and Li C (2025) Exploring NUP62’s role in cancer progression, tumor immunity, and treatment response:  \ninsights from multi-omics analysis.  \nFront. Immunol. 16:1559396 .  \ndoi: 10.3389/fimmu.2025.1559396  \nCOPYRIGHT  \n© 2025 Chen, He, Duan, Yang, Chen, Wang, Cui and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExploring NUP62’s role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis  \nLihong Chen 1†, Youfu He 2†, Menghui Duan 3, Tianwen Yang 4, Yin Chen 1, Bo Wang 5, Dejun Cui 1* and Chen Li 6*  \n1 Department of Gastroenterology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China,  \n2 Department of Cardiology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China, 3 Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning, China,  \n4 Department of Orthopaedics, Guizhou Second People’s Hospital, Guiyang, Guizhou, China, 5 Department of General Surgery, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China, 6 Department of Pharmacy, the First Afﬁliated Hospital of Guangxi Medical University, Nanning, Guangxi, China  \nBackground: NUP62, a key component of the nuclear pore complex, is closely associated with cellular functions and cancer progression . However, its expression patterns, prognostic value, and relationship with tumour immunity and drug sensitivity across multiple cancers have not been systematically studied. This study used multi-omics analyses combined with experimental validation in gastric cancer to investigate the expression, functional characteristics, and clinical relevance of NUP62 in cancer.  \nMethods: Data from TCGA, GTEx, and CPTAC databases were used to analyse the expression, mutation characteristics, and clinical associations of NUP62 . Tools such as SangerBox, TIMER 2.0, and GSEA were employed to evaluate the relationship between NUP62 and the tumour immune microenvironment, as well as its involvement in signalling pathways. Immunohistochemistry and RT-PCR were used to validate the expression of NUP62 in gastric cancer tissues. PRISM and CTRP databases were utilised to assess the correlation between NUP62 expression and drug sensitivity.  \nResults: NUP62 was signiﬁcantly upregulated in multiple cancers and was associated with poor prognosis in cancers such as clear cell renal carcinoma (KIRC), lower-grade glioma (LGG), and adrenocortical carcinoma (ACC), while playing a protective role in others, such as bladder cancer (BLCA) and stomach cancer (STAD) . Functional analyses showed that NUP62 is involved in cell cycle regulation, DNA damage repair, and tumour immunity. High NUP62 expression was signiﬁcantly correlated with increased inﬁltration of immune cells, such as macrophages and T cells, and a higher response rate to immunotherapy. Drug sensitivity analysis identiﬁed NUP62 as a marker","cbCaigpwELwJ9FrG","https://ap.wps.com/l/cbCaigpwELwJ9FrG","pdf",13886772,17,"English","# Background\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What question does the study address about NUP62?\",\"answer\":\"It examines how NUP62 expression relates to cancer progression, tumor immunity, prognosis, and treatment response, and whether these relationships differ across multiple cancer types.\"},{\"question\":\"How were NUP62 expression and immune associations analyzed?\",\"answer\":\"The study used multi-omics data from TCGA, GTEx, and CPTAC, plus tools such as SangerBox, TIMER 2.0, and GSEA to evaluate links between NUP62 and the tumor immune microenvironment and signaling pathways.\"},{\"question\":\"How was NUP62 validated in gastric cancer?\",\"answer\":\"NUP62 mRNA and protein levels in gastric cancer tissues were measured using immunohistochemistry and RT-PCR, showing higher levels in tumor tissues than in adjacent normal tissues.\"}]","Exploring NUP62’s role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis | PDF",1790158960,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a12ae38a461515eb463086eab17d4d68.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb90eb734a7905b513f0cdaefdd20be5.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4a00841001b4522ef2fae2470b8a094.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/800414e966da780ba0f7c5d2a4a232ed.webp",980,1385]